Altimmune Inc [NASDAQ: ALT] plunged by -$0.11 during the normal trading session on Thursday and reaching a high of $7.2 during the day while it closed the day at $6.78.
Altimmune Inc stock has also gained 3.67% of its value over the past 7 days. However, ALT stock has inclined by 16.70% in the 3 months of the year. Over the past six months meanwhile, it has lost -24.92% and lost -5.96% year-on date.
The market cap for ALT stock reached $549.91 million, with 81.11 million shares outstanding and 80.26 million shares in the current float. Compared to the average trading volume of 2.57M shares, ALT reached a trading volume of 5708707 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Altimmune Inc [ALT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALT shares is $22.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALT stock is a recommendation set at 1.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Altimmune Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on February 28, 2025. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on January 08, 2025, representing the official price target for Altimmune Inc stock. Previously, the target price had yet another raise to $26, while UBS analysts kept a Buy rating on ALT stock.
The Average True Range (ATR) for Altimmune Inc is set at 0.47, with the Price to Sales ratio for ALT stock in the period of the last 12 months amounting to 27495.50. The Price to Book ratio for the last quarter was 3.71, with the Price to Cash per share for the same quarter was set at 1.85.
ALT stock trade performance evaluation
Altimmune Inc [ALT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.67. With this latest performance, ALT shares gained by 23.27% in over the last four-week period, additionally sinking by -24.92% over the last 6 months – not to mention a rise of 10.97% in the past year of trading.
Altimmune Inc [ALT]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Altimmune Inc [ALT] shares currently have an operating margin of -490965.00% and a Gross Margin at -700.00%. Altimmune Inc’s Net Margin is presently recorded at -451200.00%.
Return on Equity for this stock declined to -52.22%, with Return on Assets sitting at -52.22%.
Earnings per share (EPS) analysis for Altimmune Inc [ALT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ALT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Altimmune Inc go to 0.60%.
Altimmune Inc [ALT]: Institutional Ownership
There are presently around $47.87%, or 48.23%% of ALT stock, in the hands of institutional investors. The top three institutional holders of ALT stocks are: BLACKROCK INC. with ownership of 5.32 million shares, which is approximately 7.5025%. VANGUARD GROUP INC, holding 4.91 million shares of the stock with an approximate value of $$32.63 million in ALT stocks shares; and VANGUARD GROUP INC, currently with $$26.0 million in ALT stock with ownership which is approximately 5.5119%.
